Startup to serially turn skin cells into any other cells has been launched
GC Therapeutics has entered the market to develop a commercially available platform that allows for affordable programming of induced stem cells.
The technology can be used to grow cells with defined, non-specific features and functions to target specific diseases. To begin with, the company plans to focus on cell therapy for gastrointestinal, neurological and immunological disorders.
Medicine
Biotech
6
0
0
Share
Comments
Recommended
Pavel Ryzhikh
80 subscribers
10 months ago
Subscribe
Neuralink's Revolutionary Technology: A New Era of Vision for the Blind
Neuralink has created a technology that will allow people who have lost their eyes to see, as well as those who are blind from birth (but with a healthy visual cortex).
In the first stages, such “vision” will have a low resolution, like Atari's 8-bit graphics, but gradually it will “surpass natural vision” and even allow people to see in infrared, ultraviolet or radar, Musk promises.
The U.S. D
Show more
Medicine
Biotech
8
0
0
Share
Pavel Ryzhikh
80 subscribers
10 months ago
Subscribe
FDA approved first self-administered flu vaccine
The U.S. Food and Drug Administration (FDA) has approved patients or their caregivers to self-administer the flu vaccine in the form of a nasal spray, according to a press release from the organization. The drug FluMist is approved for use to prevent influenza caused by A and B viruses in people ages 2 to 49. It was licensed for use in ages 5-49 in 2003, and 2-5 in 2007, but only when administered